Verrica Pharmaceuticals Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Verrica Pharmaceuticals Inc. (VRCA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are VRCA insiders buying or selling?
In the last 12 months, Verrica Pharmaceuticals Inc. insiders reported 9 open-market purchases ($18.2M) and 0 sales ($0) — net buying of $18.2M. Since August 2018, Trabud has recorded 126 Form 4 filings for VRCA: 52 buys ($80.8M) and 74 sells ($8.2M).
Source: SEC EDGAR Form 4
Key Statistics (August 2018 – Aug 18, 2026)
Total Form 4 filings
126
SEC EDGAR
Insider filers
17
Insider buys (52)
$80.8M
Insider sells (74)
$8.2M
Insider sentiment
Net buyingNet insider flow of $72.6M in net buying since August 2018, and $18.2M in net buying over the last 12 months. 4 insider buys in the last 90 days.
Recent VRCA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | David Zawitz | Chief Operating Officer | Purchase | 6.0K | $4.98 | $29.9K | SEC ↗ |
| Aug 18, 2026 | Jayson Rieger | CEO and President | Purchase | 25.0K | $5.03 | $125.8K | SEC ↗ |
| Aug 18, 2026 | Noah L. Rosenberg | CMO | Purchase | 6.2K | $4.91 | $30.6K | SEC ↗ |
| Aug 18, 2026 | John J. Kirby | Interim CFO | Purchase | 5.0K | $4.93 | $24.6K | SEC ↗ |
| Nov 26, 2025 | Noah L. Rosenberg | CMO | Purchase | 2.4K | $4.24 | $10.0K | SEC ↗ |
| Nov 26, 2025 | John J. Kirby | Interim CFO | Purchase | 3.5K | $4.24 | $15.0K | SEC ↗ |
| Nov 26, 2025 | David Zawitz | Chief Operating Officer | Purchase | 10.0K | $4.24 | $42.4K | SEC ↗ |
| Nov 26, 2025 | Jayson Rieger | CEO and President | Purchase | 94.3K | $4.24 | $400.1K | SEC ↗ |
| Nov 26, 2025 | Manning Paul B | Director, 10% Owner | Purchase | 4.1M | $4.24 | $17.5M | SEC ↗ |
| Mar 18, 2025 | Christopher G. Hayes | CHIEF LEGAL OFFICER | Sale | 4.3K | $0.65 | $2.8K | SEC ↗ |
| Nov 26, 2024 | Jayson Rieger | CEO and President | Purchase | 280.9K | $0.00 | $0 | SEC ↗ |
| Nov 26, 2024 | John A Stalfort III | Director | Purchase | 1.1M | $0.00 | $0 | SEC ↗ |
| Nov 26, 2024 | Manning Paul B | Director, 10% Owner | Purchase | 22.9M | $0.00 | $0 | SEC ↗ |
| Aug 28, 2024 | Christopher G. Hayes | CHIEF LEGAL OFFICER | Sale | 35.7K | $2.61 | $93.1K | SEC ↗ |
| Aug 28, 2024 | Gary Goldenberg | Chief Medical Officer | Sale | 13.5K | $2.61 | $35.2K | SEC ↗ |
| Aug 28, 2024 | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Sale | 33.7K | $2.61 | $87.8K | SEC ↗ |
| Aug 28, 2024 | Terry Kohler | CHIEF FINANCIAL OFFICER | Sale | 29.7K | $2.61 | $77.5K | SEC ↗ |
| Aug 28, 2024 | Ted White | PRESIDENT AND CEO | Sale | 34.0K | $2.61 | $88.6K | SEC ↗ |
| Jul 23, 2024 | Ted White | PRESIDENT AND CEO | Sale | 32.6K | $7.06 | $230.3K | SEC ↗ |
| Jul 23, 2024 | Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | Sale | 25.6K | $7.06 | $180.6K | SEC ↗ |
| Jul 23, 2024 | Gary Goldenberg | Chief Medical Officer | Sale | 18.5K | $7.06 | $130.7K | SEC ↗ |
| Jul 23, 2024 | Christopher G. Hayes | CHIEF LEGAL OFFICER | Sale | 21.7K | $7.06 | $153.5K | SEC ↗ |
| Dec 29, 2023 | Joseph Edelman | 10% Owner | Purchase | 321.6K | $7.17 | $2.3M | SEC ↗ |
| Dec 27, 2023 | Joseph Edelman | 10% Owner | Purchase | 504.7K | $6.45 | $3.3M | SEC ↗ |
| Dec 19, 2023 | Joseph Edelman | 10% Owner | Purchase | 1.2M | $5.63 | $6.9M | SEC ↗ |
Showing the 25 most recent of 126 Form 4 filings for Verrica Pharmaceuticals Inc..
Most active VRCA insiders
- Matt Davidson55 filings
- Manning Paul B15 filings
- Ted White11 filings
- Christopher G. Hayes8 filings
- Gary Goldenberg5 filings
Ask anything about VRCA insider activity
Use Trabud's AI agent to query Verrica Pharmaceuticals Inc.'s Form 4 history in plain English — "Show me VRCA CEO purchases this year" or compare it against any other ticker.
Open the AI agentVRCA insider trading FAQ
Are Verrica Pharmaceuticals Inc. insiders buying or selling?
In the last 12 months, Verrica Pharmaceuticals Inc. insiders reported 9 open-market purchases ($18.2M) and 0 sales ($0) — net buying of $18.2M. Since August 2018, Trabud has recorded 126 Form 4 filings for VRCA: 52 buys ($80.8M) and 74 sells ($8.2M). Over the full record that is net buying of $72.6M.
How many insiders trade VRCA stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Verrica Pharmaceuticals Inc.. The most recent filing was accepted on Aug 18, 2026.
Where does Trabud get VRCA insider trading data?
All VRCA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.